From: In silico characterization of immunogenic epitopes presented by HLA-Cw*0401
No. | Category | Source | Peptide | IC50 (nM) | Ref. |
---|---|---|---|---|---|
1 | Training Set | Cw3 consensus | FAMPNFQTL | 651 | 24 |
2 | Training Set | Cw6 consensus | IPFPIVRYL | >30000 | 24 |
3 | Training Set | Cw7 consensus | KYPDFVDAL | 2.4 | 24 |
4 | Training Set | Cw4 consensus | QYDDAVYKL | 18 | 24 |
5 | Training Set | Histone H3.3 | RYRPGTVAL | >30000 | 24 |
6 | Training Set | Unknown Cw6 natural ligand | YQFTGIKKY | >30000 | 24 |
7 | Test Set | Transcripton factor SUPT4H 56–64 | SFDGIIAMM | Binder | 10 |
8 | Test Set | Transducin-like 3 120–128 | AFDPTSTLL | Binder | 10 |
9 | Test Set | UBE3B variant 1 742–750 | VFDPALNLF | Binder | 10 |
10 | Test Set | XP_173235 3–11 | LFDITGQDF | Binder | 10 |
11 | Test Set | 8 59–67 | VYDTNPAKF | Binder | 10 |
12 | Test Set | Acyl-CoA synthetase 4 82–90 | LFDHAVSKF | Binder | 10 |
13 | Test Set | Adenosylhomocyteinehydrolase 566–574 | SFDAHLTEL | Binder | 10 |
14 | Test Set | ART-1 Adenocarcinoma antigen 21–29 | SFDLLPREF | Binder | 10 |
15 | Test Set | ATP-binding cassette, sub-family F, member 3 500–508 | YYDPKHVIF | Binder | 10 |
16 | Test Set | Block of proliferation 1 639–647 | SYDSKLVWF | Binder | 10 |
17 | Test Set | BM-015 144–152 | HFDPEVVQI | Binder | 10 |
18 | Test Set | CDC45 541–549 | HFDLSVIEL | Binder | 10 |
19 | Test Set | Cholesterol acyltransferase 72–80 | HFDDFVTNL | Binder | 10 |
20 | Test Set | Chromosome 20 open reading frame 40 318–326 | FFDNISSEL | Binder | 10 |
21 | Test Set | Elongation factor 2 265–273 | YFDPANGKF | Binder | 10 |
22 | Test Set | Epithelial cell transforming oncogene 21–29 | IFDSKVTEI | Binder | 10 |
23 | Test Set | Ethanolamine kinase EKI1 132–141 | HWDPQEVTL | Binder | 10 |
24 | Test Set | Eukaryotic translation initiation factor 3, Su 6 interacting protein 478–486 | FLDLTEGEF | Binder | 10 |
25 | Test Set | Fatty acid synthetase 544–552 | TFDDIVHSF | Binder | 10 |
26 | Test Set | FK506 binding protein 9 303–311 | VFDIHVIDF | Binder | 10 |
27 | Test Set | Glutamine:fructose-6-phosphate amidotransferase (GFAT) 345–353 | NFDDYTVNL | Binder | 10 |
28 | Test Set | Tousled-like kinase 456–464 | AFDLTEQRY | Binder | 10 |
29 | Test Set | Transcription factor IIE 144–152 | LFDPMTGTF | Binder | 10 |
30 | Test Set | HSP 70 kDa 1A 179–205 | IFDLGGGTF | Binder | 10 |
31 | Test Set | HSPC198 19–27 | SYDLFVNSF | Binder | 10 |
32 | Test Set | HSP J2 156–164 | SFDTGFTSF | Binder | 10 |
33 | Test Set | Hypothetical protein FLJ00365 80–88 | YFDAIPVTM | Binder | 10 |
34 | Test Set | Hypothetical protein FLJ11220 373–381 | YLPDFLDYF | Binder | 10 |
35 | Test Set | Hypothetical protein FLJ20343 415–423 | RFDEAYIYM | Binder | 10 |
36 | Test Set | Insuline degrading enzyme IDE 150–158 | YFDVSHEHL | Binder | 10 |
37 | Test Set | Integrin alpha-V (Vitronectin) 224–232 | KYDPNVYSI | Binder | 10 |
38 | Test Set | KCIP-1 186–194 | AFDEAIAEL | Binder | 10 |
39 | Test Set | KIAA0461 721–729 | SMDPLPVFL | Binder | 10 |
40 | Test Set | KIAA1463 444–452 | FYDERIVVV | Binder | 10 |
41 | Test Set | KIAA1921 350–358 | VYDGKIYTL | Binder | 10 |
42 | Test Set | Metalloproteinase 10 331–339 | FWPSLPSYL | Binder | 10 |
43 | Test Set | Methionine-tRNA synthetase 2 (mitochondrial) 58–66 | YYDEKVVKL | Binder | 10 |
44 | Test Set | Mucin-5B 168–176 | TFDGTSYTF | Binder | 10 |
45 | Test Set | Myosin phosphatase target subunit 1 37–45 | KFDDGAVFL | Binder | 10 |
46 | Test Set | Nuclear autoantigenic sperm protein 599–607 | QYDEAVAQF | Binder | 10 |
47 | Test Set | Nucleoporin NUP358 261–269 | SFDSALQSV | Binder | 10 |
48 | Test Set | P621 70–78 | VFDKTLAEL | Binder | 10 |
49 | Test Set | Phosphate carrier precursor 331–339 | IYDSVKVYF | Binder | 10 |
50 | Test Set | PRO2242 61–69 | YFDPQYFEF | Binder | 10 |
51 | Test Set | Protein phosphatase 6 102–110 | KWPDRITLL | Binder | 10 |
52 | Test Set | Putative prostate tumor suppressor 165–173 | TFDLQRIGF | Binder | 10 |
53 | Test Set | Rac1 168–176 | VFDEAIRAV | Binder | 10 |
54 | Test Set | RNA Helicase A 697–705 | VFDPVPVGV | Binder | 10 |
55 | Test Set | Similiar to KIAA1911 80–88 | FWDGKIVLV | Binder | 10 |
56 | Test Set | Topoisomerase I 241–249 | YYDGKVMKL | Binder | 10 |
57 | Test Set | Tensin 3 143–151 | FYDDKVSAL | Binder | 10 |
58 | Test Set | HIV-1 (BRU) gp120 350–358 | SFNCGGEFF | Binder | 18 |
59 | Test Set | HIV-1 (BRU) gag p24 307–315 | QASQEVKNW | Binder | 21 |
60 | Test Set | Synthetic peptide | AYDDAVYKL | Binder | 25 |
61 | Test Set | Cw7 consensus | AYADFVYAY | >30000 | 24 |
62 | Test Set | CKShs2 | KYFDEHYEY | >30000 | 24 |
63 | Test Set | Unknown Cw6 natural ligand | YRHDGGNVL | >30000 | 24 |
64 | Test Set | Unknown Cw7 natural ligand | NKADVILKY | >30000 | 24 |